APOB and Insulin resistance: These metabolic events are in part attributed to insulin resistance [44] and account for our finding that MHO participants have less insulin resistance and higher apoA-I, possibly accounting for a less atherogenic effect, particularly when combined with lower apoB and the apoB : apoA-I ratio [45].